Conclusively, we identified ATG10 rs10514231, rs1864183, rs4703533, and ATG16L2 rs10898880 could contribute to the efficacy and toxicity of radiotherapy in NPC patients. This evidence concerns the gene ATG16L2 and nasopharyngeal carcinoma.